RSS   Newsletter   Contact   Advertise with us
Post Online Media

Change in Novo Nordisk executive management

Jakob RiisNovo Nordisk A/S, a pharmaceutical company, announced that Jakob Riis, executive vice president, head of North America operations and president of Novo Nordisk Inc. has resigned from the company.
Article continues below

READ MORE Changes in Novo Nordisk's executive management

Effective today, Doug Langa, senior vice president for Market Access, Novo Nordisk Inc., has been appointed senior vice president, head of North America Operations and president of Novo Nordisk Inc.

Mr. Langa is senior Vice president, Market Access and a member of Novo Nordisk's US leadership team. He joined the company in 2011 as senior director, Managed Markets.

He came from GlaxoSmithKline where he was senior director of Payer Marketing.

Prior to GSK, Mr. Langa spent the majority of his career at Johnson & Johnson, where he held various roles of increasing responsibility within Managed Markets, Sales Leadership and Marketing.

He has over 25 years of experience in the pharmaceutical and medical device industry.

He graduated from Widener University and earned his MBA from Fordham University.

Mr. Riis will remain with Novo Nordisk in a transition period to help ensure a smooth handover.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy